Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anne R. McCall is active.

Publication


Featured researches published by Anne R. McCall.


Practical radiation oncology | 2017

A feasibility study of 2-mm bolus for postmastectomy radiation therapy

Lauren C. Das; Daniel W. Golden; Eugenia Perevalova; Anthony C. Wong; Kimberly De Nardo; Christopher Stepaniak; Daniel S. Joyce; B McCabe; Yasmin Hasan; Steven J. Chmura; Anne R. McCall

PURPOSE The purpose of this study was to prospectively evaluate the use of daily 2-mm bolus in patients undergoing postmastectomy radiation without reconstruction using optically stimulated luminescence dosimetry and weekly assessment of skin toxicity. METHODS AND MATERIALS We prospectively collected data from the first 49 women treated with a daily 2-mm Superflab bolus during their postmastectomy radiation therapy from 2013 to 2016 at The University of Chicago Comprehensive Cancer Center at Silver Cross. Within the first 3 days of starting radiation therapy, we measured the surface dose in vivo at 5 anatomical locations under the 2-mm bolus on the chest wall. We assessed weekly the acute skin toxicity during radiation using the National Cancer Institute Common Toxicity Criteria. Patients with reconstruction before radiation therapy were excluded. RESULTS Forty-nine women with a mean age of 54.3 years were treated with daily 2-mm bolus to the chest wall following mastectomy. Median follow-up was 32.7 weeks. The mean percentages of prescribed dose (standard deviation) for the median, central, lateral, superior, and inferior optically stimulated luminescence dosimeters were 100.1% (5.6%), 108.1% (6.7%), 98.1% (6.5%), 102.6% (8.9%), and 106.3% (6.6%), respectively. The majority (71.4%) of women experienced a maximum acute National Cancer Institute Common Toxicity Criteria skin toxicity score of 2, with only 12.2% experiencing a score of 3. There were no grade 4 toxicities. There were no local recurrences during our follow-up period. CONCLUSIONS A daily 2-mm bolus is a feasible regimen for chest wall bolus during postmastectomy radiation therapy with acceptable dose buildup and skin toxicity.


International Journal of Radiation Oncology Biology Physics | 1994

Taxol is only a weak radiosensitizer of human cervical carcinoma cell lines

Elyse Erlich; Ronald K. Potkul; Anne R. McCall; Scott Walter; Andrew T. Vaughan

Materials and Methods: The two human ceil lines C-33A (HTB 31) and MS751 (HTB 34) were exposed to 1 x10”’ M to 1 x IO” M Pactitaxel for 24 hours. At this time the drug was washed off the cells and sample exposed to graded doses of Cs-137 radiation from O-4 Gy. These samples were then incubated for approximately 7-10 days to allOW colony formation, Separate samples were also followed for at least 6 days with daily sampling for cell cycle analysis.


Gynecologic Oncology | 1993

DNA Ploidy, Proliferation Index, Grade, and Stage as Prognostic Factors for Vulvar Squamous Cell Carcinomas

James R. Dolan; Anne R. McCall; Saro Gooneratne; Scott Walter; David M. Lansky


Journal of Clinical Oncology | 2018

Readability of informed consent forms for cancer patients undergoing radiation therapy: A nationwide survey.

Subha Perni; Andrew J. Einstein; D.P. Horowitz; Michael Rooney; Daniel W. Golden; Anne R. McCall; Reshma Jagsi


Journal of Clinical Oncology | 2018

A phase 1/2A trial of synthetic DNA vaccine immunotherapy targeting HPV-16 and -18 after chemoradiation for cervical cancer.

Yasmin Hasan; Michael T. Spiotto; Larissa V. Furtado; Nita Karnik Lee; R. Brooks; Anne R. McCall; Daniel W. Golden; Shruti Jolly; Gini F. Fleming; Matthew P. Morrow; Jeffrey M. Skolnik; Mark T. Esser; Rakesh Kumar; Ralph R. Weichselbaum


International Journal of Radiation Oncology Biology Physics | 2014

Daily 2 mm Chest Wall Bolus Provides Adequate Dose Build-Up With Acceptable Skin Toxicity for Postmastectomy Radiation Therapy

L. Herman; Anthony C. Wong; E. Perevalova; Christopher Stepaniak; Daniel W. Golden; Yasmin Hasan; S.J. Chmura; Anne R. McCall


International Journal of Radiation Oncology Biology Physics | 2013

Predictive Model for the Utilization of Radiation Therapy in the Adjuvant Therapy of Women With Breast Cancer Following Breast Conserving Surgery: Results From a National Commercial and Supplemental Medicare Claims Database

A.A. Solanki; M.H. LeMieux; A.A. Chaudhary; Anne R. McCall; S.J. Chmura


International Journal of Radiation Oncology Biology Physics | 2013

Predictive Factors in the Utilization of Intensity Modulated Radiation Therapy Among Young Women Following Breast Conserving Surgery in the United States: Analysis of a National Commercial and Supplemental Claims Database

A.A. Solanki; M.H. LeMieux; A.A. Chaudhary; Anne R. McCall; S.J. Chmura


International Journal of Radiation Oncology Biology Physics | 1998

Three-dimensional dose-volume analysis in women treated with standard two-dimensional breast tangent fields

Matthew J. Krasin; Anne R. McCall; Stephanie A. King; Bahman Emami


International Journal of Radiation Oncology Biology Physics | 1996

1054 An evaluation of sexual function after surgery and/or radiation for cervical cancer

B.S. Editha A. Krueger; James R. Dolan; Ronald K. Potkul; Susan G. Fisher; Anne R. McCall

Collaboration


Dive into the Anne R. McCall's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge